Parametrica Management’s Halozyme HALO Stock Holding History

Parametrica Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-9,754	Closed	-$433K	–	109
2022 Q2	$433K	Buy	+9,754	New	+$422K	0.47%	50
2017 Q2	–	Sell	-16,367	Closed	-$212K	–	308
2017 Q1	$212K	Buy	+16,367	New	+$207K	0.22%	241
2016 Q4	–	Sell	-10,817	Closed	-$131K	–	231
2016 Q3	$131K	Buy	+10,817	New	+$111K	0.36%	119
2014 Q3	–	Sell	-29,578	Closed	-$292K	–	78
2014 Q2	$292K	Buy	+29,578	New	+$251K	2.21%	13
2013 Q4	–	Sell	-12,125	Closed	-$134K	–	144
2013 Q3	$134K	Buy	+12,125	New	+$101K	1.67%	34

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parametrica Management's HALO Position: Q3 2022 in Review

Parametrica Management sold out of Halozyme (HALO) in Q3 2022, closing a stake of 9,754 shares — an estimated $433K sold.

Parametrica Management first reported a position in HALO in Q3 2013 and held it in 5 quarters. The position peaked at $433K in Q2 2022. 357 funds tracked by Wall St. Rank hold HALO as of Q3 2022.

Parametrica Management reported no remaining Halozyme position as of Q3 2022 after selling out during the quarter.
Parametrica Management sold 9,754 Halozyme shares in Q3 2022, an estimated $433K.
Parametrica Management first reported a position in Halozyme in Q3 2013 and held it in 5 quarters.
Parametrica Management's Halozyme position peaked at $433K in Q2 2022.
357 funds tracked by Wall St. Rank held Halozyme as of Q3 2022.

Based on Parametrica Management's 13F filing for Q3 2022, filed 3 Nov 2022.